Khlood A. A. Abdeljawaad

Natural-like products as potential SARS-CoV-2 M^pro inhibitors: <i>in-silico</i> drug discovery

Mahmoud A. A. Ibrahim, Khlood A. A. Abdeljawaad, Alaa H. M. Abdelrahman et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 86 citations · Full text

Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study

Mahmoud A. A. Ibrahim, Eslam A. R. Mohamed, Alaa H. M. Abdelrahman et al. · Journal of Molecular Graphics and Modelling · 2021 · 64 citations · Full text

Antiviral Compound, Medicine, Antiviral Drug Development +7

In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors

Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Tarik A. Mohamed et al. · Molecules · 2021 · 53 citations · Full text

Non-β-Lactam Allosteric Inhibitors Target Methicillin-Resistant Staphylococcus aureus: An In Silico Drug Discovery Study

Mahmoud A. A. Ibrahim, Khlood A. A. Abdeljawaad, Alaa H. M. Abdelrahman et al. · Antibiotics · 2021 · 30 citations · Full text

In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents

Mahmoud A. A. Ibrahim, Khlood A. A. Abdeljawaad, Eslam Roshdy et al. · Scientific Reports · 2023 · 28 citations · Full text